Trials / Recruiting
RecruitingNCT06161428
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer ( SENTIVUC II)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size \>4 cm, multifocal tumors and local recurrences.
Conditions
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2026-07-01
- Completion
- 2027-07-01
- First posted
- 2023-12-07
- Last updated
- 2023-12-13
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06161428. Inclusion in this directory is not an endorsement.